Abstract
The threat of pandemic influenza is a significant concern of governments worldwide. There is a very limited and relatively expensive armament to tackle such a pandemic should it occur. This fact provides much impetus to the scientific community for the discovery of new and less expensive anti-influenza drugs. Our longstanding interest in the inhibition of influenza virus sialidase, coupled with the development of simple carbohydrates that mimic an unsaturated derivative of the enzyme's naturally-occurring ligand, N-acetylneuraminic acid, has led us to investigate the development of influenza virus sialidase inhibitors based on these mimetics. We have successfully prepared a range of these compounds, in good yield, from the relatively inexpensive carbohydrate N-acetylglucosamine utilising a short synthetic procedure. We have employed a sialidase inhibition assay for biological evaluation of the target compounds and to our delight these mimetics have displayed significant inhibition of influenza virus sialidase.
Article PDF
Similar content being viewed by others
References
Abbott, A.: What's in the medicine cabinet. Nature 435, 407–409 (2005)
Wilson, J.C., von Itzstein, M.: Recent strategies in the search for new anti-influenza therapies. Current Drug Targets 4, 389–408 (2003)
Thomson, R.J., von Itzstein, M.: N-Acetylneuraminic acid derivatives and mimetics as anti-influenza agents, In Carbohydrate-based Drug Discovery, edited by Wong C-H (Wiley-VCH, Weinheim, 2003) Vol. 2, pp. 831–862
Dyason, J.C., Wilson, J.C., von Itzstein, M.: Sialidases: Targets for rational drug design, In Computational Medicinal Chemistry and Drug Discovery, edited by Bultinck, P., De Winter, H., Langenaeker, W. and Tollenaere, J. (Dekker Inc, New York, 2004) pp. 727–745
Roberts, N.A.: Anti-influenza drugs and neuraminidase inhibitors. Progress Drug Res. 56, 197–236 (2001)
McCullers, J.A.: Antiviral therapy of influenza. Expert Opin. Investig. Drugs 14, 305–312, (2005)
Holzer, C.T., von Itzstein, M., Jin, B., Pegg, M.S., Stewart, W.P., Wu, W.Y.: Inhibition of Sialidases from Viral, Bacterial and Mammalian Sources by Analogues of 2-Deoxy-2,3-Didehydro-N-Acetylneuraminic Acid Modified at the C-4 Position. Glycoconjugate J 10, 40–44 (1993) and references within
Florio, P., Thomson, R.J., Alafaci, A., Abo, S., von Itzstein, M.: Synthesis of Δ4-β-d-glucopyranosiduronic acids as mimetics of 2,3-unsaturated sialic acids for sialidase inhibition. Bioorg. Med. Chem. Lett. 9, 2065–2068 (1999)
Mann, M.C., Thomson, R.J., von Itzstein, M.: An efficient approach to N-acetyl-d-glucosaminuronic acid-based sialylmimetics as potential sialidase inhibitors. Bioorg. Med. Chem. Lett. 14, 5555–5558 (2004)
Smith, P.W., Robinson, J.E., Evans, D.N., Sollis, S.L., Howes, P.D., Trivedi, N., Bethell, R.C.: Sialidase Inhibitors Related to Zanamivir: Synthesis and Biological Evaluation of 4H-Pyran 6-Ether and Ketone. Bioorg. Med. Chem. Lett. 9, 601–604 (1999)
Chong, A.K.J., Pegg, M.S., von Itzstein, M.: Influenza virus sialidase: Effect of calcium on steady-state kinetic parameters. Biochim. Biophys. Acta. 1077, 65–71 (1991)
Potier, M., Mameli, L., Belisle, M., Dallaire, L., Melançon, S.B.: Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-d-N-acetylneuraminate) substrate. Anal. Biochem. 94, 287–296 (1979)
Tiralongo, J., Abo, A., Danylec, B., Gerardy-Schahn, R., von Itzstein, M.: A High-Throughput Assay for Rat Liver Golgi and Saccharomyces cerevisiae-Expressed Murine CMP-N-Acetylneuraminic Acid Transport Proteins. Anal. Biochem. 285, 21–32 (2000)
Accelrys, InsightII (Accelrys Inc, San Diego)
Smith, B.J., Colman, P.M., von Itzstein, M., Danylec, B., Varghese, J.N.: Analysis of inhibitor binding in influenza virus neuraminidase. Prot. Sci. 10, 689–696 (2001)
Varghese, J.N., Smith, P.W., Sollis, S.L., Blick, T.J., Sahasrabudhe, A., McKimm-Breschkin, J.L., Colman, P.M.: Drug design against a shifting target: A structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 6, 735–746 (1998)
Sanner, M.F., Python: A programming language for software integration and development. J. Mol. Graph. Model. 17, 57–61 (1999)
Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E., Belew, R.K., Olson, A.J.: Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19, 1639–1662 (1998)
Taylor, N.R., Cleasby, A., Singh, O., Skarzynski, T., Wonacott, A.J., Smith, P.W., Sollis, S.L., Howes, P.D., Cherry, P.C., Bethell, R., Colman, P., Varghese, J.: Dihydropyrancarboxamides related to zanamivir: A new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B. J. Med. Chem. 41, 798–807 (1998)
Florio, P., Thomson, R.J., Smith, B., Colman, P.M., von Itzstein, M., (unpublished data)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mann, M.C., Islam, T., Dyason, J.C. et al. Unsaturated N-acetyl- D-glucosaminuronic acid glycosides as inhibitors of influenza virus sialidase. Glycoconj J 23, 127–133 (2006). https://doi.org/10.1007/s10719-006-5445-9
Issue Date:
DOI: https://doi.org/10.1007/s10719-006-5445-9